Inhibrx Biosciences, Inc. financial statements
Inhibrx Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 1.3M | 10-K |
| Net income | −USD 140.06M | 10-K |
| Cash and equivalents | USD 124.22M | 10-Q |
| Total debt | USD 100.56M | 10-Q |
Inhibrx Biosciences, Inc. financials on 6ix · Inhibrx Biosciences, Inc. on 6ix